Abstract
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
Titel in Übersetzung | Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023) |
---|---|
Originalsprache | Deutsch |
Seiten (von - bis) | 32-44 |
Seitenumfang | 13 |
Fachzeitschrift | Wiener Klinische Wochenschrift |
Jahrgang | 135 |
DOIs | |
Publikationsstatus | Veröffentlicht - Jan. 2023 |
Schlagwörter
- Diabetes mellitus Type 2
- Therapy Glucose lowering
ASJC Scopus Sachgebiete
- Allgemeine Medizin